Instead, CIS intensified the interaction of HIF-1α with p53 indicating that this transcription factor may act as a switch directing cells toward p53-dependent apoptosis rather than as a regulator of EC survival and angiogenesis [280]. The gene discussed is TP53; the disease is in situ carcinoma.